APA

Do A. N., Irvin M. R., Lynch A. I., Claas S. A., Boerwinkle E., Davis B. R., Ford C. E., Eckfeldt J. H., Tiwari H. K., Limdi N. A. & Arnett D. K. (20141003). The effects of angiotensinogen gene polymorphisms on cardiovascular disease outcomes during antihypertensive treatment in the GenHAT study. : Frontiers in pharmacology.

Chicago

Do Anh N, Irvin Marguerite R, Lynch Amy I, Claas Steven A, Boerwinkle Eric, Davis Barry R, Ford Charles E, Eckfeldt John H, Tiwari Hemant K, Limdi Nita A and Arnett Donna K. 20141003. The effects of angiotensinogen gene polymorphisms on cardiovascular disease outcomes during antihypertensive treatment in the GenHAT study. : Frontiers in pharmacology.

Harvard

Do A. N., Irvin M. R., Lynch A. I., Claas S. A., Boerwinkle E., Davis B. R., Ford C. E., Eckfeldt J. H., Tiwari H. K., Limdi N. A. and Arnett D. K. (20141003). The effects of angiotensinogen gene polymorphisms on cardiovascular disease outcomes during antihypertensive treatment in the GenHAT study. : Frontiers in pharmacology.

MLA

Do Anh N, Irvin Marguerite R, Lynch Amy I, Claas Steven A, Boerwinkle Eric, Davis Barry R, Ford Charles E, Eckfeldt John H, Tiwari Hemant K, Limdi Nita A and Arnett Donna K. The effects of angiotensinogen gene polymorphisms on cardiovascular disease outcomes during antihypertensive treatment in the GenHAT study. : Frontiers in pharmacology. 20141003.